Scilex Holding Co
SCLX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001820190
No open-market purchases or sales by Scilex Holding Co insiders were filed in the last 90 days; 73 institutions reported holding it in 13F filings for Q2 2026, worth $5.48M in total; no superinvestor holds it.
Other share classesSCLXW
13F holders, Q2 2024
Institutional positions in Scilex Holding Co as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 91
- −10 vs. Q1 2024
- Shares held
- 39.8M
- +11.3M (+39.4%) vs. Q1 2024
- Total value
- $76.9M
- +$31.5M (+69.3%) vs. Q1 2024
- New holders
- 14
- 13 more added
- Sold out
- 24
- 18 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SCLX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 73 | $5.48M |
| Q1 2026 | 73 | $5.81M |
| Q4 2025 | 82 | $13.7M |
| Q3 2025 | 83 | $15.0M |
| Q2 2025 | 69 | $3.72M |
| Q1 2025 | 85 | $11.3M |
| Q4 2024 | 102 | $20.9M |
| Q3 2024 | 94 | $31.6M |
| Q2 2024 | 91 | $76.9M |
| Q1 2024 | 102 | $45.5M |
| Q4 2023 | 91 | $53.4M |
| Q3 2023 | 81 | $40.7M |
| Q2 2023 | 93 | $119.8M |
| Q1 2023 | 87 | $104.2M |
| Q4 2022 | 7 | $240.1K |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Scilex Holding Co; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Omers Administration Corp | 0 | $0 | 0.00% | −36,800−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −34,120−100.0% | Sold out |
| New York Life Investment Management LLC | 0 | $0 | 0.00% | −34,109−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −30,768−100.0% | Sold out |
| CTC Alternative Strategies, Ltd. | 0 | $0 | 0.00% | −28,700−100.0% | Sold out |
| Cannon Global Investment Management, LLC | 0 | $0 | 0.00% | −25,000−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −12,682−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −4,034−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −365−100.0% | Sold out |
| Fernwood Investment Management, LLC | 0 | $0 | 0.00% | −564−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −3,101−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |